lentinan has been researched along with Cancer of Esophagus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, Z; Gu, XM; Wang, JL; Zou, JW | 1 |
| Chin, F; Hayashi, R; Isono, K; Kimura, M; Kohzu, T; Ochiai, T; Odaka, M; Okuyama, K; Onoda, S; Ryu, M; Satoh, H; Tohnosu, N; Yamamoto, Y | 1 |
| Abe, Y; Horiuchi, A; Kimura, S; Miyake, M; Miyazaki, T | 1 |
| Akimoto, M; Mori, S; Nishihira, T | 1 |
2 trial(s) available for lentinan and Cancer of Esophagus
| Article | Year |
|---|---|
Combination therapy with lentinan improves outcomes in patients with esophageal carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma; Cytokines; Drug Therapy, Combination; Esophageal Neoplasms; Female; Humans; Interleukin-10; Interleukin-12; Interleukin-2; Interleukin-4; Interleukin-6; Lentinan; Male; Middle Aged; Tegafur; Treatment Outcome | 2012 |
[Anti-cancer effects of BRMs associated with nutrition in cancer patients].
Topics: Adjuvants, Immunologic; Animals; Esophageal Neoplasms; Humans; Lentinan; Mice; Mice, Inbred C3H; Neoplasms; Nutrition Disorders; Picibanil; Stomach Neoplasms | 1988 |
2 other study(ies) available for lentinan and Cancer of Esophagus
| Article | Year |
|---|---|
[Effect of continuous intra-arterial infusion therapy with BLM-MMC-lentinan (B-M-L) in treating patients with hepatic metastases of esophageal cancer].
Topics: Aged; Bleomycin; Drug Therapy, Combination; Esophageal Neoplasms; Female; Humans; Infusions, Intra-Arterial; Lentinan; Liver Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Polysaccharides | 1982 |
The endogenous induction of tumor necrosis factor serum (TNS) for the adjuvant postoperative immunotherapy of cancer--changes in immunological markers of the blood.
Topics: Aged; Antigens, CD; Biomarkers, Tumor; Carcinoma, Hepatocellular; CD4-Positive T-Lymphocytes; Esophageal Neoplasms; Female; Humans; Immunotherapy; Interferons; Lentinan; Leukocyte Count; Liver Neoplasms; Male; Middle Aged; Pancreatic Neoplasms; Picibanil; Postoperative Period; Remission Induction; Stomach Neoplasms; T-Lymphocytes, Regulatory; Tumor Necrosis Factor-alpha | 1990 |